Table 2.

Funding years contributing to first-in-class products discovered through targeted or phenotypic methods

Metrics	Drug	Target only	Total
Funding years
All	12,840	184,015	196,855
Targeted	9,170	166,970	176,140
Phenotypic	3,670	17,045	20,715
Funding years per NME
All, n = 87 (%)	167 (7)	2,390 (93)	2,557
Targeted, n = 77 (%)	137 (5)	2,492 (95)	2,629
Phenotypic, n = 10 (%)	367 (18)	1,704 (82)	2,071

Funding years associated with multiple NMEs are not unique.